CRVO

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 1.92 M1.76 M322.57 K8 7260 2.09 M Gross profit 1.92 M1.76 M322.57 K8 7260 2.09 M Operating expenses 7.22 M8.37 M8.37 M8.34 M8.11 M 33.19 M Selling/general/admin expenses 2.38 M3.27 M2.33 M2.51 M2.98 M 11.08 M Research & development 4.84 M5.11 M6.04 M5.83 M5.14 M 22.11 M Operating income -5.3 M-6.62 M-8.04 M-8.33 M-8.11 M -31.1 M Non-Operating Income, Total 408.85 K357.87 K317.56 K244.23 K146.37 K 1.07 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 408.99 K368.13 K318.79 K240.94 K147.39 K 1.08 M Unusual income/expense -135-10.26 K-1 2273 291-1 021 -9 213 Pretax income -4.89 M-6.26 M-7.73 M-8.09 M-7.96 M -30.04 M Equity in earnings ————— — Taxes ———11.34 M— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -4.89 M-6.26 M-7.73 M-8.09 M-7.96 M -30.04 M Discontinued operations ————— — Net income -4.89 M-6.26 M-7.73 M-8.09 M-7.96 M -30.04 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -4.89 M-6.26 M-7.73 M-8.09 M-7.96 M -30.04 M Basic earnings per share (Basic EPS) -0.56-0.7-0.84-0.88-0.86 -3.28 Diluted earnings per share (Diluted EPS) -0.56-0.7-0.84-0.89-0.86 -3.29 Average basic shares outstanding 8.7 M8.95 M9.25 M9.04 M9.26 M — Diluted shares outstanding 8.7 M8.95 M9.25 M9.04 M9.26 M — EBITDA —-6.85 M-8.27 M-8.48 M-8.18 M -31.77 M EBIT -5.3 M-6.62 M-8.04 M-8.33 M-8.11 M -31.1 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) —-234.67 K-221.53 K-146.06 K-70.1 K -672.35 K